Science ❯ Biotechnology

Drug Discovery

Artificial Intelligence Clinical Research AI in Medicine AI in Healthcare AI Applications Molecular Licensing Molecular Simulation Cancer Research Clinical Studies Optogenetics Computational Modeling Proprietary Platforms Virtual Cell Modeling Antibody Development Regulatory Science Clinical Trials Bioengineering

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

The purchase brings a first-in-class MLLT1/3 protein degrader into Amgen’s oncology research.

Chai Discovery Raises $130 Million Series B at $1.3 Billion Valuation

Google Launches Interactions API and Upgraded Gemini Deep Research for Developers

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch

Integrated Biosciences’ Optogenetic Platform Advances Toward Aging and Pan-Antiviral Therapies